Clinical Associate Professor University of British Columbia North Vancouver, British Columbia, Canada
Objectives : This analysis examined whether Canada has any national post-NICU neurodevelopmental surveillance infrastructure, despite comprehensive acute-care datasets such as the Canadian Neonatal Network (CNN) and Evidence-based Practice for Improving Quality (EPIQ), which together track over 30,000 NICU admissions annually. Canadian capacity was compared with international systems used in Nordic countries, Surveillance of Cerebral Palsy in Europe (SCPE) member states, and Australia’s state-based cerebral palsy (CP) registries.
Design: A targeted policy review assessed three areas: (1) CNN and EPIQ variable dictionaries, follow-up scope, and data governance; (2) provincial neonatal follow-up programs and associated databases; and (3) international surveillance models including Nordic integrated registries, SCPE frameworks, and Australian state registries. Extracted variables included diagnostic fields, early detection metrics, standardized developmental outcomes, reporting structures, and public accessibility.
Results: CNN and EPIQ contain no CP diagnostic variables, high-risk designations, or validated developmental screening results such as General Movements Assessment, Ages and Stages Questionnaires, or Bayley assessments, and neither dataset extends beyond the NICU stay. Canada has no mechanism linking acute-care records to developmental surveillance. Provincial follow-up programs lack standardized protocols or common data definitions, preventing national aggregation. In contrast, Nordic countries integrate neonatal through CP registry data with mandatory reporting. SCPE’s 20+ member states use harmonized definitions enabling cross-national benchmarking of diagnostic practices. Australia aggregates state CP registry data reporting incidence and functional outcomes. Denmark publicly reports a median CP diagnostic age of 18 months, enabling evaluation of early detection performance. Canada has no comparable national metrics. Without coordinated surveillance, Canada cannot monitor whether high-risk infants receive timely assessment or evaluate provincial variation in diagnostic age.
Conclusion: Canada’s absence of national developmental surveillance represents a critical gap relative to feasible international models. This limits quality improvement, accountability for early identification, and evidence-based resource allocation for developmental services.
